The genetic basis of hyperuricaemia and gout. [Joint Bone Spine. 2010] - PubMed result

Joint Bone Spine. 2010 May 14. [Epub ahead of print]

The genetic basis of hyperuricaemia and gout.
Merriman TR, Dalbeth N.

Department of Biochemistry, University of Otago, PO Box 56, Dunedin, New Zealand.

Abstract
Gout results from elevated urate concentrations in the blood (hyperuricaemia). When super-saturation of urate is reached, monosodium urate crystals form within the joint. In some individuals, these crystals elicit a painful self-limiting inflammatory response that is characteristic of acute gouty arthritis. The most important cause of hyperuricaemia is reduced excretion of uric acid in the urine. Uric acid excretion is coordinated by a suite of urate transport molecules expressed in the renal collecting tubules, and is a key physiological checkpoint in gout. Other checkpoints in gout are hepatic production of urate, monosodium urate crystal formation, and initiation of the acute inflammatory response. Genome-wide association scans for genes regulating serum urate concentrations have identified two major regulators of hyperuricaemia- the renal urate transporters SLC2A9 and ABCG2. The risk variants at each gene approximately double the risk for gout in people of Caucasian ancestry, with SLC2A9 also resulting in higher risk for gout in people of Polynesian ancestry, a diverse population characterized by a high prevalence of gout. Ongoing genetic association studies are identifying and confirming other genes controlling serum urate concentrations; although genome-wide association studies in gout per se await recruitment of suitable case sample sets. Copyright © 2010 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

PMID: 20472486 [PubMed - as supplied by publisher]

open here please:
The genetic basis of hyperuricaemia and gout. [Joint Bone Spine. 2010] - PubMed result